Stay updated on Pembrolizumab in SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in SCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label at the bottom of the page was updated from v3.6.5 to v3.6.6. This indicates a minor site or template update, with no changes to the study details displayed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a newer revision label, v3.6.5, replacing the previous v3.6.4, indicating a small maintenance update to the page's metadata. This change does not alter the study details or content presented on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows a new revision tag 'Revision: v3.6.4', replacing the previous 'Revision: v3.6.3'. This indicates a small update to the page version without changing the study information or content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page shows a new revision label (v3.6.3) replacing the previous v3.6.2, indicating a deployment/update of the page build without altering study content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision indicator was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor internal update to the page template or content.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status on the page now shows 'No longer looking for participants,' and the Intervention/Treatment label has been standardized. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the revision tag updated to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.